AGIOS PHARMACEUTICALS, INC. 10-Q filing
Filed 2025-10-30 · Report date 2025-09-30 · 2025
Filing metadata
- Accession number
- 0001439222-25-000116
- Form type
- 10-Q
- CIK
- 0001439222
- Primary document
- https://www.sec.gov/Archives/edgar/data/1439222/000143922225000116/agio-20250930.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for AGIOS PHARMACEUTICALS, INC..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $34.1M | - | - |
| Cost Of Revenue | $4.5M | - | - |
| Operating Income | $-350.6M | - | - |
| Net Income | $-304.7M | - | - |
| Eps Basic | -5.27 | - | - |
| Eps Diluted | -5.27 | - | - |
| Cash And Equivalents | $92.7M | - | - |
| Total Assets | $1.4B | - | - |
| Total Liabilities | $101.4M | - | - |
| Shareholders Equity | $1.3B | - | - |
| Operating Cash Flow | $-276.8M | - | - |
| Capital Expenditures | $3.2M | - | - |